Incidental pulmonary emboli in lymphoma patients are associated with aggressive disease and poor prognosis

Journal of Thrombosis and Haemostasis

Volumn 8, Issue 12, 2010, Pages 2835-2836

  Grigoropoulos, N F ^a   Shaw, A S ^a   Hampson, F A ^a   Baglin, T P ^a   Follows, G A ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; HISTOPATHOLOGY; HUMAN; LARGE CELL LYMPHOMA; LETTER; LUNG EMBOLISM; MORBIDITY; NONHODGKIN LYMPHOMA; OVERALL SURVIVAL; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; THROMBOEMBOLISM;

HUMANS; LYMPHOMA, NON-HODGKIN; PROGNOSIS; PULMONARY EMBOLISM;

EID: 78650010346     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2010.04061.x     Document Type: Letter

References (14)

1. Carrier M, Righini M, Wells P, Perrier A, Anderson D, Rodger M, Pleasance S, Le Gal G. Subsegmental pulmonary embolism diagnosed by computed tomography: incidence and clinical implications. A systematic review and meta-analysis of the management outcome studies. J Thromb Haemost 2010; 8: 1716-22.
2. Sorensen HT, Mellemkjar L, Olsen JH, Baron JA. Prognosis of cancers associated with venous thromboembolism. N Engl J Med 2000; 343: 1846-50.
3. Mohren M, Markmann I, Jentsch-Ullrich K, Koenigsmann M, Lutze G, Franke A. Increased risk of thromboembolism in patients with malignant lymphoma: a single-centre analysis. Br J Cancer 2005; 92: 1349-51.
4. Cronin CG, Lohan DG, Keane M, Roche C, Murphy JM. Prevalence and significance of asymptomatic venous thromboembolic disease found on oncologic staging CT. Am J Roentgenol, 2007; 189: 162-70.
5. Sehn LH, Berry B, Chhanabhai M, Fitzgerald C, Gill K, Hoskins P, Klasa R, Savage KJ, Shenkier T, Sutherland J, Gascoyne RD, Connors JM. The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP. Blood 2007; 109: 1857-61.
6. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982; 5: 649-56.
7. Falanga A, Marchetti M. Venous thromboembolism in the hematologic malignancies. J Clin Oncol 2009; 27: 4848-57.
8. Gladish GW, C DH, Marom EM, Sabloff BS, Broemeling LD, Munden RF. Incidental pulmonary emboli in oncology patients: prevalence, CT evaluation, and natural history. Radiology 2006; 240: 246-55.
9. Stein PDHJ. Prevalence of acute pulmonary embolism among patients in a general hospital and at autopsy. Chest 1995; 108: 978-81.
10. Gosselin MV, Rubin GD, Leung AN, Huang J, Rizk NW. Unsuspected pulmonary embolism: prospective detection on routine helical CT scans. Radiology 1998; 208: 209-15.
11. Eyer BA, Goodman LR, Washington L. Clinicians' response to radiologists' reports of isolated subsegmental pulmonary embolism or inconclusive interpretation of pulmonary embolism using MDCT. Am J Roentgenol 2005; 184: 623-8.
12. Desai SR. Unsuspected pulmonary embolism on CT scanning: yet another headache for clinicians? Thorax 2007; 62: 470-2.
13. Van Rossum AB, Van Houwelingen HC, Kieft GJ, Pattynama PM. Prevalence of deep vein thrombosis in suspected and proven pulmonary embolism: a meta-analysis. Br J Radiol 1998; 71: 1260-5.
14. Kearon C, Kahn SR, Agnelli G, Goldhaber S, Raskob GE, Comerota AJ. Antithrombotic therapy for venous thromboembolic disease. Chest 2008; 133: 454S-545S.